Interferon-based cytokine therapy for advanced renal cell carcinoma

Acta Urologica Japonica

Volumn 51, Issue 8, 2005, Pages 499-502

  Takayama, Tatsuya ^a   Kai, Fumitake ^a   Sugiyama, Takayuki ^a   Furuse, Hiroshi ^a   Mugiya, Soichi ^a   Ozono, Seiichiro ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Advanced renal cell carcinoma; Cytokine

Indexed keywords

CYTOKINE; INTERFERON;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CANCER THERAPY; CHILD; FEMALE; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; PROGNOSIS; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; CARCINOMA, RENAL CELL; FEMALE; HUMANS; INTERFERON TYPE II; INTERFERON-ALPHA; INTERFERONS; INTERLEUKIN-2; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; SURVIVAL RATE;

EID: 24644470144     PISSN: 00181994     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Mickisch GH, Garin A, van Poppel H, et al.: European Organisation for Research and Treatment of Cancer (EORTC) Genitourinary Group: radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial. Lancet 358: 966-970, 2001
2. Flanigan RC, Salmon SE, Blumenstein BA, et al.: Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med 345: 1655-1659, 2001
3. Motzer RJ, Bacik J, Schwartz LH, et al.: Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma. J Clin Oncol 22: 454-463, 2004
4. Negrier S, Escudier B, Gomez F, et al.: Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Francais d'Immunotherapie. Ann Oncol 13: 1460-1468, 2002